"We partnered with Biomedical Strategy Consultants initially to do some limited market sizing/ opportunity assessment work, but quickly realized that despite their small size they are able to activate high quality, healthcare savvy resources to not just do market analysis but help solve business problems. We were so pleased with the quality of their work and responsiveness that we have since asked them to help us sort out our distribution strategy and do a more focused study on a key growing market segment. We have now used them on four successive projects in two different countries (China and India).

I’ve been particularly pleased by their strong customer focus. Rather that worry about whether certain questions or problems are in scope on a project, they have focused on helping us get the answers we need. Their project organization skills are first class, and they have been able to communicate effectively with different levels of our organization. I believe they are so effective, because the team at Biomedical Strategy Consultants is made up entirely of people with strong line management experience in multi-national healthcare firms operating in Asia. In their past, they have been in our position, so they know almost intuitively what we want and how we want it done! "

Robert L. Larson

Director, Business Development & Marketing Asia Pacific

STERIS Corporation

"Biomedical Strategy Consultants listened to and understood our business objectives, and sought to uncover key aspects of local market dynamics with energy and focus. Their Japanese consultants added a level of understanding of how the market operates which could only come from business experience gained over many years of practice in that region.

The final report was presented in a very professional manner, and summarized strategic options for growth based on newly acquired information plus their considerable industry insights. Their analysis and recommendations provided a well thought through choice of alternative Japanese market development strategies."

Dr. Alastair Mcleod

Business Director, Pressure Area Care

Huntleigh Healthcare plc

"We engaged Biomedical Strategy Consultants for a major strategy development and opportunity assessment project in China. Their industry network in Asia is very impressive and they were quickly able to arrange face-to-face interviews in Mandarin with leading clinicians .

Biomedical Strategy Consultants provided invaluable market insights and helped us gain an in-depth understanding of the dynamics of the Chinese medical device market. The strategies and recommendations developed through the project allowed us to present a meaningful plan of action to our Board of Directors.

The team at Biomedical Strategy Consultants is extremely responsive and has been a pleasure to work with. We highly recommend them and look forward to working with them again on our future activities in Asia-Pacific."

Edward Wholihan

CFO & Vice President Business Development

Inovise Medical, Inc.

"Utah Medical Products, Inc. (UTMD) engaged Biomedical Strategy Consultants to perform a distributor search for the Japanese medical device market. From the onset, they treated their consultancy as a business partnership, rather than simply a vendor–customer relationship. The team at Biomedical Strategy Consultants seemed keenly aware that listening to what UTMD wanted was extremely important to provide the result UTMD was seeking.

UTMD was impressed with their knowledge of the Japanese medical device market. It was apparent that both Fredrik Nyberg and Ray Tsunoda had worked in and had many contacts within the Japanese market. They went above and beyond the consulting agreement by not only successfully completing the engagement but also identifying and supporting UTMD’s efforts to secure other, peripheral opportunities.

UTMD recommends Biomedical Strategy Consultants to other medical device companies seeking to penetrate the Japanese market."

Greg LeClaire

Chief Financial Officer

Utah Medical Products, Inc.

"At the end of 2002 Syncor International was acquired by Cardinal Health in a transaction that had a value of approximately US $900 million at the time of close. Cardinal Health made a decision to divest both the Medical Imaging and International businesses of Syncor International and I was asked, as the former President and CEO of Syncor International to develop and implement a plan for the timely sale of these businesses.

I engaged Biomedical Strategy Consultants to assist me and the divestiture team in accomplishing a number of critical objectives:

Under Kin Chua’s leadership as interim manager, performance against each of these objectives far exceeded my expectations and as a result Cardinal Health was successful in completing the sale of these businesses to new owners within a period of eight months."

Bob Funari

Former President & CEO

Syncor International, Inc. (now a unit of Cardinal Health, Inc.)

"As a major Asian provider of CNC precision-machined components, Spindex recently embarked on a project to explore diversification into the medical device industry. Biomedical Strategy Consultants were of great help in researching opportunities in the global market of orthopaedic implants and instruments. They introduced us to high quality prospective buyers in the industry and provided a detailed map of the market dynamics.

Their research, analysis and recommendations proved invaluable in defining our entry strategy. The quality of their work was consistently above our expectations. They are highly competent, professional and responsive. I enjoyed working with Fredrik and his team and can thoroughly recommend them to any contract manufacturer planning to enter the biomedical industry.

Thanks for a job well done!"

Choo Heng Thong

Managing Director

Spindex Industries Limited

Back to Top